Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Avantor’s Dr. Ger Brophy shares thoughts on overcoming bioproduction challenges, how biomanufacturers can better work with their suppliers as they develop new treatments and therapies, and the future of the evolving cell and gene therapy market.